NEWSDr. In-San Kim, a co-founder of SHIFTBIO INC., has been appointed as a fellow researcher at the Korea Institute of Science and Technology (KIST)

4 Nov 2022

The KIST fellow system is a new system established last year. This KIST fellow system supports to those eminent scholars for their continuous outstanding research activities, who have already made global-leading accomplishments.

The KIST explained Dr. Kim was selected as a Fellow member because “Dr. In-San Kim is an extraordinarily eminent integrative medicine scholar in Korea. Recently, he also proved himself as a global leader through the achievements of research on drug development based on natural nanoparticles, Ferrtine, and Extracellular Vesicles (EVs). Additionally, EV-based new drug platform technology, which is Dr. In-San Kim’s main field of study, is a branch with endless potential to be developed and utilized as a rare disease treatment research in our future.”

You can reach out to the full content by clicking the links below.